STANDARD BIOTOOLS INC.

Analyst Reco. Standard BioTools Inc.

Equities

LAB

US34385P1084

Market Closed - Nasdaq Other stock markets 01:45:00 04/05/2024 am IST			5-day change	1st Jan Change
2.51 ^USD	-0.79%		+2.87%	+13.57%

25/04	Sector Update: Health Care Stocks Decline Late Afternoon	MT
25/04	Sector Update: Health Care	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target	16/04	MT
Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target	04/04	MT
KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology	12/23/12	MT
BTIG Adjusts Fluidigm's Price Target to $10 From $12, Reiterates Buy Rating	16/21/16	MT
FLUIDIGM : UBS Adjusts Fluidigm's Price Target to $9 From $10, Reiterates Buy Rating	11/21/11	MT
FLUIDIGM : UBS Adjusts Fluidigm's Price Target to $10 From $15, Citing Lower Revenue Forecasts for COVID Testing Business; Buy Rating Kept	07/21/07	MT
FLUIDIGM : Piper Sandler Adjusts Fluidigm's Price Target to $15 from $12, Maintains Overweight Rating	10/20/10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer